Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer, Cancer Cell International

Acute myeloid leukemia - Wikipedia

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International

American Journal of Hematology, Blood Research Journal

Frontiers Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

The clinical impact of the molecular landscape of acute myeloid leukemia

Frontiers Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy

Promising Results in Phase 1 Study of Novel Menin Inhibitor for Aggressive Leukemia

High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia